mosliciguat
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 21, 2019 (NCT03754660)
Timeline
Indications
Mechanism of action
NPR1 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07185321 | Phase 1 | Jun 10, 2025 | Roivant Sciences, Inc. |
| NCT06635850 | Phase 2 | Nov 30, 2024 | Roivant Sciences, Inc. |
| NCT03754660 | Phase 1 | Jan 21, 2019 | Bayer |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Roivant Sciences, Inc. | For profit | 2 | 2 | 2 | 2024 |
| Bayer | For profit | 1 | 1 | 1 | 2019 |
2 organizations
Page 1 / 1